Bone regenerative effects of recombinant human bone morphogenetic protein-2 employed protein transduction domain |
Jung, Sung-Won
(Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Kim, Nam-Hee (Department of Oral pathology, Oral Cancer Research institute, College of Dentistry, Yonsei University) Yook, Jong-In (Department of Oral pathology, Oral Cancer Research institute, College of Dentistry, Yonsei University) Kim, Chang-Sung (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University) Kim, Hyung-Jun (Department of Oral & Maxillofacial surgery, College of Dentistry, Yonsei University) Cho, Kyoo-Sung (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University) |
1 | Ahn SH, Kim CS, Suk HJ, et al, Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects. J Periodontol 2003:74:787-797 DOI ScienceOn |
2 | Frankel AD, Pabo CO, Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988:55:1189-1193 DOI ScienceOn |
3 | Tseng YL, Liu JJ, Hong RL. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol Pharmacal 2002: 62:864-872 DOI ScienceOn |
4 | Schmitz JP. Hollinger JO. The critical size defect as an experimental model for eraniomandibulofacial nonunions. Clin Orthop Relat Res 1986:299-308 |
5 | Wang EA, Rosen V, D'Alessandro JS, et al Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990:87:2220-2224 |
6 | Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000:142:9-21 DOI |
7 | Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22:233-241 DOI ScienceOn |
8 | Winn SR, Hu Y, Sfeir C, Hollinger JO. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 2000:42: 121-138 DOI ScienceOn |
9 | Baum BJ. Kok M, Tran SD, Yamano S. The impact of gene therapy on dentistry: a revisiting after six years. J Am Dent Assoc 2002:133:35-44 DOI |
10 | Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci USA 1996:93:878-883 |
11 | Amano M, Chihara K. Kimura K, et al FormaLion of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997; 275 : 1308 -1311 DOI ScienceOn |
12 | Lewin M, Carlesso N. Tung CH. et al, Tat peptide-rierivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Bioteclmol 2000: 18:410-414 DOI ScienceOn |
13 | Schwarze SR, Hruska KA., Dowdy SF. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol 2000: 10: 290-295 DOI ScienceOn |
14 | Celeste AJ, Iannazzi JA. Taylor RC, et al, Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87: 9843-9847 |
15 | Sampath TK, Maliakal JC, Hauschka PV, et al, Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and dif- ferentiation in vitro, J Biol Chem 1992:267: 20352-20362 PUBMED |
16 | Cook SD, Baffes GC. Wolfe MW, et al 3rd. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects, J Bone Joint Surg Am 1994:76:827-838 DOI PUBMED |
17 | Cook SD, Salkeld SL, Patron LP. Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose, J Biomed Mater Res B Appl Biomater 2005; 75:137-145 PUBMED |
18 | Baltzer AW, Lattermann C, Whalen JD, et al, Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000:7:734-739 PUBMED |
19 | King GN, Cochran DL. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review. J Periodontol 2002: 73:925-936 DOI ScienceOn |
20 | Hong SJ, Kim CS. Han DK, et al, The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-3816 DOI ScienceOn |
21 | Fittipaldi A, Ferrari A, Zoppe M, et al Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem 2003:278:34141-34149 DOI ScienceOn |
22 | Choi SH, Kim CK, Cho KS, et al, Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ ACS) on healing in 3-wall in- trabony defects in dogs, J Periodontal 2002;73:63-72 DOI ScienceOn |
23 | Park J, Ryu J, Kim KA, et al, Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells J Gen Viral 2002: 83: 1173-1181 DOI |
24 | Michiue H, Tomizawa K, Wei FY, et al, The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-rnediated p53 protein transduction, J Biol Chem 2005: 280: 8285-8289 DOI ScienceOn |
25 | Wikesjo UM, Guglielmoni P, Promsudthi A, et al, Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999:26:392-400 DOI ScienceOn |
26 | Schwarze SR, Dowdy SF, In vivo protein transduction: intracellular delivery of biologically active proteins. compounds and DNA, Trends Pharmacal Sci 2000:21:45-48 DOI ScienceOn |
27 | Pang EK, Im SU, Kim CS, et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model J Periodontal 2004;75: 1364-1370 DOI ScienceOn |
28 | Derossi D, Joliot AH, Chassaing G, Frochiantz A. The third helix of the Antennapedia homeodomain translacates through biological membranes. J Biol Chem 1994: 269: 10444 -10450 |
29 | Gitelman SE, Kobrin MS, Ye JQ, et al, Recombinant Vgr-l/RMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994: 126: 1595-1609 DOI |
30 | Fawell S, Seery J, Daikh Y, et al Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994:91: 664-668 |
31 | Hyun SJ, Han DK, Choi SH, et al Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects, J Periodontal 2005: 76:1667-1674 DOI ScienceOn |
32 | Wadia JS, Stan RV, Dowdy SF, Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004:10:310-315 DOI ScienceOn |
33 | Han DK, Kim CS, Jung UW, et al Effect of a fibrin-fibroncctin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontal 2005: 76: 2216-2222 DOI ScienceOn |
34 | Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988: 242: 1528-15:34 DOI |
35 | Urist MR, Bone: formation by autoinduction, 1965, Clin Orthop Relat Res 2002:4-10 |
36 | Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 2001;83-A Suppl 1:S1-6 |
37 | Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 1982: 196: 100-109 DOI PUBMED ScienceOn |